These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Value of ephedrine-ethlenediamine as an appetite depressant: comparison with d-amphetamine sulfate. KUPERSMITH IH Curr Ther Res Clin Exp; 1960 Feb; 2():39-42. PubMed ID: 14412826 [No Abstract] [Full Text] [Related]
3. Psychologic factors in obesity and anorexic drugs. KROGER WS Am Pract Dig Treat; 1959 Dec; 10():2169-71. PubMed ID: 14412107 [No Abstract] [Full Text] [Related]
4. Evaluation of amphetamine as an appetite depressant. GALLAGHER NI; KNIGHT WA J Chronic Dis; 1958 Aug; 8(2):244-52. PubMed ID: 13563605 [No Abstract] [Full Text] [Related]
5. THE USES AND ABUSES OF APPETITE SUPPRESSANTS. SEATON DA; DUNCAN LJ Br J Clin Pract; 1965 Feb; 19():89-93. PubMed ID: 14258387 [No Abstract] [Full Text] [Related]
6. Use of appetite-suppressant drugs for weight reduction without dieting. FISH CH Clin Med (Northfield); 1962 Feb; 69():427-30. PubMed ID: 15445746 [No Abstract] [Full Text] [Related]
7. A double-blind study of an anorexigenic combination. ROSENBERG BA Curr Ther Res Clin Exp; 1961 Feb; 3():45-50. PubMed ID: 13743379 [No Abstract] [Full Text] [Related]
8. [Lucofene- a new anorexigenic drug for the treatment of obesity]. MUNE O; ENGBERG PALLESEN A Ugeskr Laeger; 1960 May; 122():605-11. PubMed ID: 14425244 [No Abstract] [Full Text] [Related]
9. A COMPARISON OF THE APPETITE SUPPRESSING PROPERTIES OF DEXAMPHETAMINE AND PHENTERMINE. SEATON DA; ROSE K; DUNCAN LJ Scott Med J; 1964 Nov; 9():482-5. PubMed ID: 14231545 [No Abstract] [Full Text] [Related]
10. USE OF AN AMPHETAMINE-COMBINATION DRUG IN AN ANTI-OBESITY CLINIC. BERMAN MI; ANDERSON IR Md State Med J; 1965 Jan; 14():29-31. PubMed ID: 14233312 [No Abstract] [Full Text] [Related]
11. [ON THE DRUG THERAPY OF OBESITY]. NEUBERT D Z Arztl Fortbild (Berl); 1965 Feb; 54():134-46. PubMed ID: 14266804 [No Abstract] [Full Text] [Related]
12. Use of a sustained-release meprobamate-amphetamine preparation in treating obesity. RODENSKY PL Curr Ther Res Clin Exp; 1961 Dec; 3():526-9. PubMed ID: 14493098 [No Abstract] [Full Text] [Related]
13. [Mode of action and indication for appetite depressants in the treatment of obesity]. Stauffacher W Schweiz Med Wochenschr; 1975 Apr; 105(15):461-6. PubMed ID: 1124373 [TBL] [Abstract][Full Text] [Related]
14. Appetite control in pregnancy using combined prochlorperazine-dextroamphetamine. VIGLIONE JP Clin Med (Northfield); 1962 May; 69():1157-60. PubMed ID: 15445884 [No Abstract] [Full Text] [Related]
16. Phenmetrazine and dexamphetamine in the management of obesity. HAMPSON J; LORAINE JA; STRONG JA Lancet; 1960 Jun; 1(7137):1265-7. PubMed ID: 14399386 [No Abstract] [Full Text] [Related]
17. Benzphetamine in the management of obesity-controlled studies. PAVER RL Rocky Mt Med J; 1963 Feb; 60():37-9. PubMed ID: 13942074 [No Abstract] [Full Text] [Related]
18. [Loss of weight with dexedrine in medical practice]. JOHANNESSEN SG Ugeskr Laeger; 1960 Jan; 122():84. PubMed ID: 14407363 [No Abstract] [Full Text] [Related]
19. MANAGEMENT OF THE OBESE PATIENT: A REVIEW OF ADJUNCTIVE MEASURES. EHRMANTRAUT WR; SAVARESE CJ J Am Med Womens Assoc; 1964 Sep; 19():750-4. PubMed ID: 14173959 [No Abstract] [Full Text] [Related]
20. A comparison of anorexigenic drugs in the treatment of the resistant obese patient. KROGER WS Psychosomatics; 1962; 3():454-7. PubMed ID: 14035909 [No Abstract] [Full Text] [Related] [Next] [New Search]